Ana Sousa-Herves

Prof. Ana Sousa-Herves

Universidad de Castilla-La Mancha. Facultad de Farmacia de Albacete, Albacete-02008, Spain
orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 September 2011 in Pharmaceutical Research
Verified
Journal Article
Closed access
PDF file
ELEnrique Lallana
Enrique Lallana
Ana Sousa-HervesAna Sousa-Herves
Ana Sousa-Herves
FFFrancisco Fernandez-Trillo
Francisco Fernandez-Trillo
RRRicardo Riguera
Ricardo Riguera
EFEduardo Fernandez-Megia
Eduardo Fernandez-Megia

25 January 2012 in Pharmaceutical Research
Verified
Journal Article
Closed access
PDF file
ELEnrique Lallana
Enrique Lallana
FFFrancisco Fernandez-Trillo
Francisco Fernandez-Trillo
Ana Sousa-HervesAna Sousa-Herves
Ana Sousa-Herves
RRRicardo Riguera
Ricardo Riguera
EFEduardo Fernandez-Megia
Eduardo Fernandez-Megia

1 October 2012 in Current Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
MAM. Asadian-Birjand
M. Asadian-Birjand
Ana Sousa-HervesAna Sousa-Herves
Ana Sousa-Herves
DSD. Steinhilber
D. Steinhilber
JCJ.C. Cuggino
J.C. Cuggino
MCMarcelo Calderon
Marcelo Calderon
This review addresses current and future perspectives of nanogel technology for nanomedicine. The synthetic methodologies and material properties of nanogels prepared by chemical meanings are discussed in detail, and examples that illustrate the different methodologies are presented. Applications in the fields of drug and gene delivery, smart imaging modalities, responsive materials, and multivalency as a therapeutic approach highlight the enormous potential of the functional nanogels as novel polymeric platforms for biomedicine.

4 October 2017 in eLife
Verified
Journal Article
Open access
SFShiran Ferber
Shiran Ferber
GTGalia Tiram
Galia Tiram
Ana Sousa-HervesAna Sousa-Herves
Ana Sousa-Herves
AEAnat Eldar-Boock
Anat Eldar-Boock
AKAdva Krivitsky
Adva Krivitsky
RSRonit Satchi-Fainaro
Ronit Satchi-Fainaro
Glioblastoma is a highly aggressive brain tumor. Current standard-of-care results in a marginal therapeutic outcome, partly due to acquirement of resistance and insufficient blood-brain barrier (BBB) penetration of chemotherapeutics. To circumvent these limitations, we conjugated the chemotherapy paclitaxel (PTX) to a dendritic polyglycerol sulfate (dPGS) nanocarrier. dPGS is able to cross the BBB, bind to P/L-selectins and accumulate selectively in intracranial tumors. We show that dPGS has dual targeting properties, as we found that P-selectin is not only expressed on tumor endothelium but also on glioblastoma cells. We delivered dPGS-PTX in combination with a peptidomimetic of the anti-angiogenic protein thrombospondin-1 (TSP-1 PM). This combination resulted in a remarkable synergistic anticancer effect on intracranial human and murine glioblastoma via induction of Fas and Fas-L, with no side effects compared to free PTX or temozolomide. This study shows that our unique therapeutic approach offers a viable alternative for the treatment of glioblastoma.

11 January 2012 in Expert Opinion on Drug Delivery
Verified
Journal Article
Closed access
JGJose Gonzalez
Jose Gonzalez
MLMaría Lozano-López
María Lozano-López
Ana Sousa-HervesAna Sousa-Herves
Ana Sousa-Herves
EFEduardo Fernandez-Megia
Eduardo Fernandez-Megia
NCNoemi Csaba
Noemi Csaba
Introduction: Advances achieved over the last few years in drug delivery have provided novel and versatile possibilities for the treatment of various diseases. Among the biomaterials applied in this field, it is worth highlighting the increasing importance of polyaminoacids and polypeptides. The appealing properties of these polymers are very promising for the design of novel compositions in a variety of drug delivery applications. Areas covered: This review provides an overview on the general characteristics of polyaminoacids and polypeptides and briefly discusses different synthetic pathways for their production. This is followed by a detailed description of different drug delivery applications of these polymers, emphasizing those examples that already reached advanced preclinical development or have entered clinical trials. Expert opinion: Polyaminoacids and polypeptides are gaining much attention in drug delivery due to their exceptional properties. Their application as polymers for drug delivery purposes has been sped up by the significant achievements related to their synthesis. Certainly, cancer therapy has benefited the most from these advances, although other fields such as vaccine delivery and alternative administration routes are also being successfully explored. The design of new entities based on polyaminoacids and polypeptides and the improved insight gained in drug delivery guarantee exciting findings in the near future.

9 January 2021 in Polymers
Verified
Journal Article
Open access
PDF file
Antonio Sanchez RuizAntonio Sanchez Ruiz
Antonio Sanchez Ruiz
Ana Sousa-HervesAna Sousa-Herves
Ana Sousa-Herves
JBJuan Tolosa Barrilero
Juan Tolosa Barrilero
ANAmparo Navarro
Amparo Navarro
Joaquín C. García-MartinezJoaquín C. García-Martinez
Joaquín C. García-Martinez
Aggregation-Induced Emission (AIE) in organic molecules has recently attracted the attention of the scientific community because of their potential applications in different fields. Compared to small molecules, little attention has been paid to polymers and oligomers that exhibit AIE, despite having excellent properties such as high emission efficiency in aggregate and solid states, signal amplification effect, good processability and the availability of multiple functionalization sites. In addition to these features, if the molecular structure is fully conjugated, intramolecular electronic interactions between the composing chromophores may appear, thus giving rise to a wealth of new photophysical properties. In this review, we focus on selected fully conjugated oligomers, dendrimers and polymers, and briefly summarize their synthetic routes, fluorescence properties and potential applications. An exhaustive comparison between spectroscopic results in solution and aggregates or in solid state has been collected in almost all examples, and an opinion on the future direction of the field is briefly stated.